Patients with adenocarcinoma in situ of the uterine cervix with microscopic infiltration can be treated by surgery, radiotherapy and chemotherapy, and the prognosis is usually better. Cervical cancer is a common malignant tumor of the female reproductive system, and its occurrence is related to human papillomavirus infection, heredity and other factors. Adenocarcinoma in situ with minimal infiltration indicates that the lesion is limited, without lymph nodes and distant metastasis. Patients with adenocarcinoma in situ with microinvasion of the cervix can be treated with radical surgery, such as total hysterectomy, followed by radiotherapy according to the condition. After surgery, radiotherapy can be supplemented according to the condition. After active treatment, patients can usually get a better prognosis, and the five-year survival rate can be up to 90%. After surgery, patients should follow the doctor’s instructions for regular checkups, and maintain good habits in daily life, such as not staying up late at night and exercising appropriately, etc., which can reduce the recurrence rate and prolong the survival period to a certain extent.